Condition
Neuroendocrine Neoplasm
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 7 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
7 shownGenetic Bases of Neuroendocrine Neoplasms in Mexican PatientsNCT06523582 · 2022-08-03
RECRUITINGDetermining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersNCT07118176 · 2025-08-01
ACTIVE_NOT_RECRUITINGA Phase 1 Study of ZSP1602 in Participants With Advanced Solid TumorsNCT03734913 · 2019-01-25
UNKNOWNTesting Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid TumorsNCT03375320 · 2018-10-26
ACTIVE_NOT_RECRUITINGDual SSTR2 and Integrin αvβ3 Targeting PET/CT ImagingNCT02817945 · 2016-06-01
UNKNOWNPembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung CancerNCT02402920 · 2015-07-22
COMPLETEDRomidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionNCT01638533 · 2012-08-03
COMPLETEDCommon interventions
Computed TomographyPROCEDURE268Ga-NOTA-3P-TATE-RGDDRUG1Biospecimen CollectionPROCEDURE1Cabozantinib S-malateDRUG1CarboplatinDRUG1CisplatinDRUG1EtoposideDRUG1Fludeoxyglucose F-18OTHER1Gallium Ga 68 FAPi-46RADIATION1Laboratory Biomarker AnalysisOTHER1Magnetic Resonance ImagingPROCEDURE1PembrolizumabBIOLOGICAL1Pharmacological StudyOTHER1Placebo AdministrationOTHER1Positron Emission TomographyPROCEDURE1Quality-of-Life AssessmentOTHER1Radiation TherapyPROCEDURE1RomidepsinDRUG1X-Ray ImagingPROCEDURE1ZSP1602DRUG1
Leading sponsors
Trial status mix
ACTIVE_NOT_RECRUITING2
COMPLETED2
UNKNOWN2
RECRUITING1
Phase mix
PHASE14
EARLY_PHASE11
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.